Fremont, CA, United States of America

Jenny Louie-Helm

This inventor holds 14 USPTO granted patents and 3 published patent applications, plus 2 CIPO patents and 1 EPO patent. Top assignee: Depomed, Inc.. Active years: 1999-2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jenny Louie-Helm. Retrieved from https://idiyas.com/inventor/jenny-louie-helm

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 14 

% Patents Active = 35.7



Average Co-Inventor Count = 3.0

ph-index = 11

Forward Citations = 1,255(Granted Patents)


Location History:

  • Union City, CA (US) (1999 - 2014)
  • Fremont, CA (US) (2011 - 2018)

Company Filing History:


Years Active: 1999-2018

Loading Chart...
Loading Chart...
Loading Chart...
14 patents (USPTO):Explore Patents

Title: The Innovative Mind of Jenny Louie-Helm

Introduction

Jenny Louie-Helm, located in Fremont, California, is a prolific inventor with an impressive portfolio of 14 patents. Her work primarily focuses on advancements in pharmacology, particularly in the development of oral dosage forms that enhance drug delivery systems.

Latest Patents

One of Louie-Helm's latest innovations is a gastric retentive oral dosage form with restricted drug release specifically designed for the lower gastrointestinal tract. This controlled release formulation ensures the pharmacologically active agent is primarily administered to the stomach, duodenum, and upper regions of the small intestine, thus optimizing therapeutic effects while minimizing unwanted side effects. The matrix consists of a biocompatible, hydrophilic, erodible polymer that swells in the presence of water and gradually erodes, controlling the drug release rate based on the erosion rate.

Another significant patent is the shell-and-core dosage form that approaches a zero-order drug release. This innovative design features an outer shell that surrounds a core containing the drug. The shell facilitates the diffusion of the drug while also promoting gastric retention through swelling upon contact with gastric fluid. This innovation is especially advantageous in achieving controlled drug release in postprandial scenarios.

Career Highlights

Jenny Louie-Helm plays a vital role at Depomed, Inc., where she contributes to the company's mission of advancing drug delivery systems. Her inventive spirit and technical expertise have led to notable improvements in the efficacy of oral medications, positioning her as a key player in the pharmaceutical landscape.

Collaborations

Throughout her career, Louie-Helm has collaborated with esteemed colleagues such as Bret Berner and John N. Shell. These collaborations have proven fruitful, resulting in significant advancements in their shared field of research and development.

Conclusion

With her remarkable track record and continuous innovations in the realm of drug delivery systems, Jenny Louie-Helm exemplifies the spirit of creativity and dedication that drives scientific advancements. Her contributions not only enhance pharmacological practices but also improve the quality of patient care, solidifying her reputation as an influential inventor in the industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…